Literature DB >> 6709234

Effects of electrical stimulation of various midline thalamic nuclei on the bilateral release of dopamine from dendrites and nerve terminals of neurons in the nigro-striatal dopaminergic pathways.

A Chéramy, R Romo, G Godeheu, J Glowinski.   

Abstract

The effects of electrical stimulation of midline thalamic nuclei on the release of [3H]dopamine ( [3H]DA) were determined in both substantiae nigrae (SN) and caudate nuclei of halothane-anesthetized cats using the push-pull cannula method. [3H]DA release was increased in the four structures following stimulation of the interanteromedialis nucleus (IAM) but only enhanced in both SN when nucleus reuniens (RE) was stimulated. In contrast, no effect was detected after delivery of the stimuli to nucleus centralis medialis. These results indicate that the anterior part of the thalamic massa intermedia (IAM and RE particularly) is involved in the bilateral regulation of DA release from nerve terminals and dendrites of the nigro-striatal dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6709234     DOI: 10.1016/0304-3940(84)90080-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Regulation of dopamine function in the nucleus accumbens of the rat by the thalamic paraventricular nucleus and adjacent midline nuclei.

Authors:  M W Jones; I C Kilpatrick; O T Phillipson
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  Dopamine function in the prefrontal cortex of the rat is sensitive to a reduction of tonic GABA-mediated inhibition in the thalamic mediodorsal nucleus.

Authors:  M W Jones; I C Kilpatrick; O T Phillipson
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

3.  Structural connectivity of the human massa intermedia: A probabilistic tractography study.

Authors:  Alireza Borghei; Irem Kapucu; Robert Dawe; Mehmet Kocak; Sepehr Sani
Journal:  Hum Brain Mapp       Date:  2021-01-20       Impact factor: 5.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.